Rain Therapeutics (NASDAQ:RAIN) reported quarterly losses of $(0.68) per share which met the analyst consensus estimate. This is a 2.86 percent increase over losses of $(0.70) per share from the same period last year.
Related Posts
Sony To List Financial Unit After PS5 Sales Disappointment
Sony Group Corp (NY has revealed plans to take its financial arm public in October 2025. This decision follows a significant reduction in the sales forecast for its core gaming division, which was attributed to underwhelming PlayStation 5 (PS5) sales.
Accel Entertainment, Inc. Q4 Adj. EPS $0.24 Beats $0.22 Estimate, Sales $278.07M Beat $275.42M Estimate
Accel Entertainment, Inc. (NYSE:ACEL) reported quarterly earnings of $0.24 per share which beat the analyst consensus estimate of $0.22 by 9.09 percent. This is a 33.33 percent increase over earnings of $0.18 per share
How To Earn $500 A Month From Lowe’s Stock Ahead Of Q1 Earnings Report
Lowe's Companies, Inc (NYSE: LOW) to release Q1 earnings before opening bell on Tuesday. Analysts expect $2.93 per share, down from $3.67 last year.